{"prompt": "['MEIRAGTx', 'CNGA3CNGA3 Gene Therapy trial for Achromatopsia', '10 References', 'Aboshiha J, Dubis AM, Carroll J, et al. The cone dysfunction syndromes. Br J Ophthalmol', '2016;100(1):115-121.', 'Annear,M.J., Bartoe,J.T., Barker,S.E Smith,A.J., Curran,P.G., Bainbridge,J.W Ali,R.R., and Petersen-', 'Jones,S.M. (2011). Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.', 'Gene Ther. 18, 53-61.', 'Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE,', 'Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS,', \"Moore AT, Ali RR. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl\", 'J', 'Med, 2008, 358:2231-9', 'Bainbridge JW, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, Georgiadis A, Mowat FM,', 'Beattie SG, Gardner PJ, Feathers KL, Luong VA, Yzer S, Balaggan K, Viswanathan A, de Ravel TJL,', 'Casteels I, Holder GE, Tyler N, Fitzke FW, Weleber RG, Nardini M, Moore AT, Thompson DA, Petersen-', 'Jones SM, Michaelides M, van den Born LI, Stockman A, Smith AJ, Rubin G and Ali RR. Long-term effect', 'of gene therapy on Leber Congenital amaurosis. N Eng J Med, 2015, 372: 1887-97.', 'Balaggan KS, Duran Y, Georgiadis A, et al. Absence of ocular malignant transformation after sub-', 'retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient mice. Gene therapy', '2012;19(2):182-188.', 'Chan AW, Tetzlaff JM, Altman DG et Al. SPIRIT 2013 Statement: Defining Protocol Items for Clinical', 'Trials. Ann Intern Med 2013; 158:200-207.', 'Chan AW, Tetzlaff, Gotzsche et Al. SPIRIT 2013 explanation and elaboration: guidance for protocols of', 'clinical trials. BMJ 2013; 346: e7586.', 'Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor', 'EA, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW.', 'Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with', 'slow rod kinetics. Proc Natl Acad Sci U S A, 2008.105:15112-7.', 'Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB,', 'Schwartz SB, Kom\u00e1romy AM, Hauswirth WW, Aguirre GD. Human retinal gene therapy for Leber', 'congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.', 'Proc Natl Acad Sci U A, 2013, 110(6):E517-25.', 'Daya S and Berns Kl. Gene therapy using Adeno-associated virus vectors. Clin Microbiol Rev', '2008;21(4):583-593.', 'Kohl. S, Jagle. H, and Wissinger. B, 2013, Achromatopsia, GeneReviews - NCBI Bookshelf: National', 'Institute of Health', 'Russell SR, Bennett J, High KA, et al. Phase III trial of AAV2-hRPE65v2 (SPK-RPE65) to treat RPE65-', 'mediated inherited retinal dystrophies (IRDs): top-line safety and efficacy results. Presented at the', 'Retina Society Annual Scientific Meeting, Paris, 10 October 2015.', 'CNGA3 MGT012 Protocol version 6.0 16Apr2021', 'Page 67 of 68']['MEIRAGTy', 'CNGA3CNGA3 Gene Therapy trial for Achromatopsia', 'Russell SR, Bennett J, Wellmann JA, et al. Efficacy and safety of voretigene neparvovec', '(AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised,', 'controlled, open-label, phase 3 trial. The Lancet 2017;390(10097):849-860', 'Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working', 'Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First', 'International Workshop. Am J Ophthalmol, 2005, 140:509-516.', 'Judd DB. Facts of color-blindness. J Opt Soc Amer 1943;33:294-307', 'Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F,', \"Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R,\", 'Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ,', \"McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber's\", 'congenital amaurosis. N Engl J Med, 2008, 358:2240-8.', 'Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B,', 'Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF,', 'Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA,', 'Kay MA. Nat Med, 2006, 12:342-7', 'Michaelides M, Hunt DM, and Moore AT. The cone dysfunction syndromes. Br J Ophthalmol', '2004;88(2):291-297', 'Natkunarajah M, Trittibach P, Mclntosh J, Duran Y, Barker SE, Smith AJ, Nathwani AC, Ali RR.', 'Assessment of ocular transduction using single-stranded and self-complementary recombinant', 'adeno-associated virus serotype 2/8. Gene Ther, 2008, 15:463-7.', 'Nowrouzi A, Penaud-Budloo M, Kaeppel C, Appelt U, Le Guiner C, Moullier P, Kalle CV, Snyder RO,', 'Schmidt M. Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human', 'Primate Skeletal Muscle and Liver. Mol Ther, 2012, 20(6):1177-86.', 'Sharpe LT and Nordby K. Total colour-blindness: an introduction. In: Night Vision: Basic, Clinical and', 'Applied Aspects. R. F. Hess, L. T. Sharpe and K. Nordby. Cambridge, Cambridge University Press', '1990:253-289.', 'Sharpe LT, Stockman A, J\u00e4gle H, et al. Opsin genes, cone photopigments, color vision, and color', 'blindness. In: Color Vision: from Genes to Perception. KR Gegenfurtner and Sharpe LT (Eds).', 'Cambridge University Press 1999:1-51.', 'Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, Le Meur G, Deschamps JY, Provost N,', 'Nivard D, Cherel Y, Moullier P, Rolling F. Subretinal delivery of recombinant AAV serotype 8 vector in', 'dogs results in gene transfer to neurons in the brain. Mol Ther, 2008,16:916-23.', 'Vandenberghe LH, Bell P, Maguire AM, et al. AAV9 targets cone photoreceptors in the nonhuman', 'primate retina. PLoS One 2013;8:e53463.', 'Vandenberghe LH, Bell P, Maguire AM, et al. Dosage thresholds for AAV2 and AAV8 photoreceptor', 'gene therapy in monkey. Sci Transl Med 2011;3:88ra54.', 'CNGA3 MGT012 Protocol version 6.0 16Apr2021', 'Page 68 of 68']\n\n###\n\n", "completion": "END"}